Trademark: 79130027
Word
ACTAVIS LABORATORIES
Status Date
Monday, November 21, 2022
Registration Number
4686257
Registration Date
Tuesday, February 17, 2015
Filing Date
Wednesday, November 21, 2012
Published for Opposition
Tuesday, March 11, 2014
Cancellation Date
Monday, November 21, 2022
5 Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; oral contraceptives; contraceptive preparations; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels; pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum for the treatment or prevention of halitosis, cavities, gingivitis, plaque, and dry mouth; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases, all primarily composed of test strips, collection containers, medical diagnostic reagents and assays; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators
3 Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care; cosmetic skin fresheners and toners; cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, non-medicated mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth
1 Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for the prevention and treatment of illnesses, diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the sensory system, and the genitourinary system, in the treatment of inflammatory disorders and diseases, and for treatment in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and gastroenterology; and chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry
42 Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis
Color is not claimed as a feature of the mark.
"LABORATORIES"
Jun 17, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jun 17, 2023
Death Of International Registration
Oct 22, 2022
New Representative At Ib Received
Aug 22, 2022
Total Invalidation Processed By The Ib
Aug 2, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Aug 2, 2022
Invalidation Processed
May 3, 2022
Total Invalidation Of Reg Ext Protection Created
Sep 3, 2021
Cancelled Section 71
Feb 17, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 17, 2015
Final Decision Transaction Processed By Ib
Jul 1, 2015
Final Disposition Notice Sent To Ib
Jul 1, 2015
Final Disposition Processed
May 17, 2015
Final Disposition Notice Created, To Be Sent To Ib
Feb 17, 2015
Registered-Principal Register
Jan 14, 2015
Ttab Release Case To Trademarks
Jan 14, 2015
Opposition Terminated No. 999999
Jan 14, 2015
Opposition Dismissed No. 999999
Oct 3, 2014
Refusal Processed By Ib
Sep 4, 2014
Opposition Instituted No. 999999
Sep 3, 2014
Opposition Notice (Ib Refusal) Sent To Ib
Sep 3, 2014
Opposition Notice (Ib Refusal) Created
Mar 24, 2014
Extension Of Time To Oppose Received
Mar 11, 2014
Official Gazette Publication Confirmation E-Mailed
Mar 11, 2014
Published For Opposition
Mar 7, 2014
Notification Processed By Ib
Feb 19, 2014
Notification Of Possible Opposition Sent To Ib
Feb 19, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 19, 2014
Notification Of Notice Of Publication E-Mailed
Feb 4, 2014
Law Office Publication Review Completed
Feb 4, 2014
Approved For Pub - Principal Register
Feb 4, 2014
Examiner's Amendment Entered
Feb 4, 2014
Assigned To Lie
Feb 4, 2014
Examiner's Amendment Entered
Feb 3, 2014
Notification Of Examiners Amendment E-Mailed
Feb 3, 2014
Examiners Amendment E-Mailed
Feb 3, 2014
Examiners Amendment -Written
Aug 28, 2013
Notification Of Final Refusal Emailed
Aug 28, 2013
Final Refusal E-Mailed
Aug 28, 2013
Final Refusal Written
Jul 25, 2013
Teas/Email Correspondence Entered
Jul 24, 2013
Correspondence Received In Law Office
Jul 24, 2013
Teas Response To Office Action Received
Jul 16, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 16, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 9, 2013
Correction From Ib Entered - Attorney Review Required
Jul 6, 2013
Correction Transaction Received From Ib
Jul 1, 2013
Refusal Processed By Ib
Jun 7, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Jun 7, 2013
Refusal Processed By Mpu
Jun 7, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Jun 6, 2013
Non-Final Action Written
Jun 4, 2013
Application Filing Receipt Mailed
May 31, 2013
Assigned To Examiner
May 31, 2013
New Application Office Supplied Data Entered
May 30, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
